Deadline for early-bird payment is Dec 31, 2014; then the registration would be canceled and the abstracts would be removed

Instructions for Authors

Print

 

 The Asian Journal of Pharmaceutical Sciences

 

Scope of the journal

The Asian Journal of Pharmaceutical Sciences publishes research papers, review, and short communications dealing with drug controlled release systems, drug targeting, physical pharmacy, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering and materials science.

 

Ethical issues

The Hong Kong Asiamed Publishing House is committed to the timely publication of peer-reviewed articles in journals and encyclopedias. The Hong Kong Asiamed Publishing House requires all authors to comply fully with current ethical standards for publication in their disciplines. Manuscripts submitted to the journal must represent reports of original research, and the original data must be available for review by the editor if necessary. All authors of a manuscript must have agreed to its submission and are responsible for its content, including appropriate citations and acknowledgments, and must also have agreed that the corresponding author has the authority to act on their behalf in all matters pertaining to publication of the manuscript. By submission of a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, and is not being considered for publication elsewhere. When submitting papers for publication, it is expected that the authors will provide written assurance and describe the novelty of their work or in the approach taken in their research in a covering letter.

 

Copyright

To maintain and protect the Society’s ownership and rights and to provide scientists the opportunity to publish in high-quality journals, the Asian Journal of Pharmaceutical Sciences requires the corresponding author to sign a copyright transfer agreement on behalf of all the authors. This agreement will be sent to the corresponding author when the manuscript is accepted and scheduled for publication. Unless this agreement is received, the journal will not publish the manuscript.

 

Submission of manuscripts

Authors are should submit their manuscripts through email to This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Review process

All manuscripts are anonymously reviewed by the editors, members of the editorial board, or invited reviewers. When a manuscript is submitted to the journal, it is given a number and assigned to two reviewers. The reviewers operate under strict guidelines and are expected to complete their reviews quickly. Within 6 to 8 weeks after submission, the corresponding author will be notified of the editor’s decision on acceptance, revision, further review, or rejection. When revisions are requested, the corresponding author must submit the revised paper within 2 months. If you can't complete the revision within this deadline for some reasons, please contact us to prolong time. Otherwise, your revised paper after 2 months will be considered as a new submission, Manuscripts that have been rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided in the appropriate field on the submission form.

 

Manuscript preparation

The manuscripts must be type-written in clear, grammatically correct English with no typographical errors. Manuscripts that do not meet the minimal requirements for English grammar and composition will be rejected immediately. If the manuscript is not consistent with the journal instructions, or contain illegible text and substandard illustrations, it will be returned to the authors.

The paper should be written in A4 page with line space of 1.5 times, continuous line numbers and numbered pages, and page margin of2.54 cm. Please use one font type of “Times New Roman” and font size of “12 pt”. The paper should be numbered using items numbers in the following format “1. ××; 2. ××; 2.1. ××; 2.1.1. ××……….”. Leave one space after a comma, except in chemical names, for example, 1,2,3,4-tetramethyl. For the identification of pharmaceutical substances, the International Nonproprietary Names (INN) proposed and recommended by the WHO should be used. For the units of measurement, the use of the International System of Units (SI) is recommended: m (meter), g (gram), kg (kilogram), μg (microgram), s (second), min (minute), h (hour), d (day), y (year), l (litre), μl (microlitre), ng/ml not ng•ml-1. Excessive abbreviations should be avoided and abbreviations other than those acknowledged, uniform and standard should be contained in brackets at their first use. The first letter of the sentence is asked to be in capitalization in all the titles and secondary titles. The common name of the drug is asked to be in lower-case character, and the first initial of the brand name is in capitalization.

 

Research papers New, significant, innovative and original findings are suitable as Research papers.

The following sections are required and should be arranged in the following order: Cover Letter, graphical abstract, Manuscript [Title page, Abstract, Keywords, 1. Introduction, 2. Materials and methods, 3. Results and discussion, 4. Conclusion, (Acknowledgements), References, Figure and Table legends, Figures, Tables].

 

Cover letter The manuscripts should be submitted with a cover letter declaring that the study was conducted in compliance with international, national and institutional regulations pertaining to animal experiments and clinical studies. It should also be clearly stated that the study protocol complies with a particular recommendation and was approved for use. The cover letter should explicitly state that the manuscript has not been previously published in any language anywhere and that it is not under simultaneous consideration by another journal. Authors must describe in a covering letter, when submitting papers for publication, the novelty of their work or in the approach taken in their research. It is welcomed that the brief introduction of the first author and the corresponding author sent in attached file.

 

Graphical abstract Authors must supply a graphical abstract (which will be published in the Journal’s Table of Contents) for all types of manuscripts at the time the paper is submitted. A graphical abstract should allow readers to quickly gain an understanding of the main take-home message of the paper and is intended to encourage browsing, promote interdisciplinary scholarship, and help readers identify more quickly which papers are most relevant to their research interests. The graphical abstract should summarize the contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership. The graphical abstract consists of a brief introduction (limited to 50 words in length) and a figure highlighting clearly the key findings described in the paper and specially prepared for Table of Contents. A key, summarizing figure or scheme taken from the original paper can also be submitted as a graphical abstract. The figure could be in the form of a structure, reaction/mechanism scheme, graphical data, formulation process, photograph etc., but tables or spectra are not recommended. The content of the graphical abstract should be kept within an area of 5 cmby 17 cm, and figure should have a minimum resolution of 300 dpi and line art should be between 1000 dpi and 1200 dpi. Color and beautiful figure is encouraged. The graphical abstract should be included in the second page of the uploaded Word file following the cover letter. The authors are asked to supply the materials in the following format: full title, authors, brief Introduction of the study, and figure.

 

Title page Please give the title (capital for first character), running title (not to exceed 50 characters and spaces), name of each author (first name + surname) with an asterisk indicating the corresponding author, and each author’s affiliation. If the affiliations of the other authors are different from the first author, designate affiliations of other authors using a superscript (a,b,c). The detailed mailing address, telephone number (+country number-district number-tel number), fax number, and e-mail address are required for the corresponding author.

 

Abstract A structured abstract not exceeding 250 words should be arranged. Avoid abbreviations and references, and do not include diagrams. The abstract with keywords should be typed on a separate sheet.

 

Keywords Below the abstract, type 3-6 keywords or short phrases suitable for indexing. With the first letter of each keyword capitalized, separated with “;”.

 

Introduction The introduction should not be an extensive literature review although it should provide sufficient background information for the reader to understand and evaluate the results of the present study without referring to previous publications on the same topic.

 

Materials and methods The section should include sufficient technical information to allow the experiments to be repeated. Procedural detail that has been published previously should be referred to by citation. When a modified procedure is used, only the author's modifications of the previously published method need to be given in detail. Please do not include any result in this part.

 

Results and discussion Results should be described as concisely as possible in one of the following ways: text, table(s), or figure(s). Avoid extensive use of graphs to present data that might be more concisely or more comprehensively presented in the figures or tables. The number of tables and figures should be restricted to 4 and 8 respectively. The reproducibility and statistical significance ofmeasurements, material or biological data, must be included where relevant. The discussion should provide an interpretation of the results and their significance with regard to previously published work. There should not be any significant repetition of the experimental procedures or reiteration of the introduction.

 

Conclusion A short, paragraph summarizing the most important finding(s) of the research is required.

 

Acknowledgments The source of any financial support, gifts, technical assistance and advice received for the work being published must be indicated in the Acknowledgments section.

 

References Responsibility for the accuracy of bibliographic citations lies entirely with authors. Citations of literature in the text must be presented in numerical order and a separate reference list should be supplied. Type numbers in square brackets and do not use superscripts. References should include the list of authors (first name-abbreviated+last name, the first 3 authors are list, and then the 'et al' is followed), title of the article (in capital for the first letter of the title), Journal (in abbreviation)/Book title, (book publisher), year, volume number and page number, e.g.

[1] Francis MF, Lavoie L, Winnik FM, et al. Solubilization of cyclosporine A in dextran-g-polyethyleneglycolalkylether polymeric micelles. Eur J Pharm Biopharm. 2003, 56: 337-346.

 

Figure and Table legends Please locate (cite) the Tables and Figures in the text. Tables should be unified as Table X in the text, and Figures should be unified as Fig. X in the text (X is Arabic number). The captions for Figures and Tables should be typed on a separate sheet of paper under “Figure and Table legends”. The total numbers of the Tables + Figures should be not more than 12 for research paper.

Figures Figures (photographs, drawing, diagrams and charts) are to be numbered in one consecutive series of Arabic numerals in the order in which they are cited in the text and abbreviated as Fig. X. The width of the figure should be about 8 cm or 16 cm (but not more than 16 cm) and in figures the font of words must be of “Times New Roman” with font size of 9 pt, which especially for the X-axis and Y-axis together with their quantum and unity. Data in the Figures should be expressed as mean ± SD, so the SD data should be added during the profiling dissolution, release, and concentration-time curves, etc. The figures should be clear enough with a minimum resolution of 300 dpi. Please delete the unnecessary background in the figure. It is very important to tell us what software you used to form the every figure. Excel, Origin or other software? Please send the Original files to us, or insert them in your manuscript which can be opened in the Original files by double clicking. It will be helpful for typesetting your paper if it is accepted for publication.

Tables All tables must be numbered consecutively (using Arabic numerals) and be cited in the text. Titles should be short but descriptive. Each table should be on a separate sheet, together with a legend and/or footnotes identified by superscripts a, b, c, etc. Do not use vertical lines and keep horizontal rules to a minimum. In tables, the units are usually in brackets following the quantity, and the font should be Times New Roman and size of 9 pt. Data in the Tables should be expressed as mean ± SD.

Formula and equations Structural and chemical formula, process flow diagrams and complicated mathematical expressions should be very clearly presented. All subscripts, Greek letters and unusual characters must be identified. Structural and chemical formulae as well as process flow diagrams should be prepared in the same way as graphs. The equations (formula) should be formed by the special formula editor in Word. The structures of drug should be drawn in the special ChemDraw software and inserted them in the Word file, and also be insured to enter the ChemDraw file by double-clicking them.

Review articles

Review articles should contain up-to-date information providing comprehensive coverage of relevant literature. All format requirements are similar to those applicable to research papers. Review articles need not be divided into sections such as Materials and methods, and Results and discussion, but should definitely have an abstract, introduction and conclusion. The numbers of the references in the review should not exceed 100.

Short communications

The research and technical communications section of this journal (maximum 2,500 words) is open to interesting results worthy of publication without requiring extensive introduction and discussion. It also includes preliminary data or studies that did not provideenough information for a Research paper. This section should be organized as well as the research paper. The total numbers of Figures plus Tables should be not more than 6. Tables, figures and references are to be arranged in the same way as Research papers. Brevity of presentation is essential for this section.

Manuscript revision by authors Two files are necessary for the Manuscript revision. (1) Response to comments: a detailed, point-by-point response to each point rose, specifically describing all changes, or the reason why no change was made. The sections are required for every comment raised by reviewer, which are Comment, Answer, and Revision (Listing the revisions and indicating the places where it was in the text). In order to expedite the processing of the revised manuscript, please be as specific as possible in your response to the reviewer(s). Further consideration will be possible only if you send point-by-point responses to the reviewers and the editors. (2) The revised manuscript in Word highlighting the changes to your manuscript by using the track changes mode in MS Word or by using bold or colored text. The general formats are in accordance with the original submitted manuscript.

Proofreading Corrections are restricted to printing errors. Answer all queries (in the interest of accuracy) on the proof. Make all corrections legibly (preferably by typing) in the margins, or point out the mistakes in another separate file.

Copyright transfer agreement Authors will be asked to sign a transfer of copyright form when the papers are accepted for publication and be typesetted. All authors must read and agree to the conditions of copyright form and return the signed Copyright Transfer Agreement within 10 d. 

 

 


Writing a scientific paper
 
 
 

 

As long as, you are willing to join us, please mark BioNat-IV 2015 in your calendar